LT - Neutrofilų elastazės inhibitoriaus alvelestato panaudojimas kvėpavimo sistemos ligų, nulemtų alfa-1 antitripsino nepakankamumo, gydymui
EN - METHODS INVOLVING NEUTROPHIL ELASTASE INHIBITOR ALVELESTAT FOR TREATING RESPIRATORY DISEASE MEDIATED BY ALPHA-1 ANTITRYPSIN DEFICIENCY
Legal status
Patent in force
Bibliographic data
Indications of the International Patent Classification (IPC)
(51) |
INT.CL. |
A61K 31/444 |
(2006.01) |
|
|
A61K 45/06 |
(2006.01) |
|
|
A61P 11/00 |
(2006.01) |
|
|
A61P 29/00 |
(2006.01) |
European patent
(11) |
Number of the document |
4106757 |
(13) |
Kind of document |
T |
(96) |
European patent application number |
21714345.2 |
|
Date of filing the European patent application |
2021-03-16 |
(97) |
Date of publication of the European application |
2022-12-28 |
(45) |
Date of publication and mention of the grant of the patent |
2023-08-23
|
(46) |
Date of publication of the claims translation |
2023-11-10
|
PCT application
(86) |
Number |
PCT/GB2021/050653 |
|
Date |
2021-03-16 |
PCT application publication
(87) |
Number |
WO 2021/209739 |
|
Date |
2021-10-21 |
Priority applications
(30) |
Number |
Date |
Country code |
|
202005519 |
2020-04-16
|
GB |
|
202005520 |
2020-04-16
|
GB |
|
202062706195 P |
2020-08-04
|
US |
Inventors
(72) |
PARKIN, Jacqueline , GB
|
Grantee
(73) |
Mereo Biopharma 4 Limited ,
1 Cavendish Place, London
Greater London W1G 0QF,
GB
|
Attorney or representative
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
Title
(54) |
Neutrofilų elastazės inhibitoriaus alvelestato panaudojimas kvėpavimo sistemos ligų, nulemtų alfa-1 antitripsino nepakankamumo, gydymui |
|
METHODS INVOLVING NEUTROPHIL ELASTASE INHIBITOR ALVELESTAT FOR TREATING RESPIRATORY DISEASE MEDIATED BY ALPHA-1 ANTITRYPSIN DEFICIENCY |
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2025-01-21 |
5 |
115.00
EUR
|
Next renewal fee
|
2026-03-16 |